doi.org/10.1016/j.molimm.2018.05.003

Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation

..., Minhui Dai
25
Molecular Immunology3.00
Volume: 99, Pages: 134 - 144
Published: May 26, 2018
Paper Fields
Paper Details
Title
Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation
DOI
doi.org/10.1016/j.molimm.2018.05.003
Published Date
May 26, 2018
Journal
Molecular Immunology
Volume
99
Pages
134 - 144
© 2026 Pluto Labs All rights reserved.